Table 1 Summary of patient characteristics from MT-04
Placebo | ACARIZAX | |
|---|---|---|
No. of subjects | 277 | 282 |
Sex (%) | ||
Male | 151 (55 %) | 147 (52 %) |
Female | 126 (45 %) | 135 (48 %) |
Mean age (SD) | 33.0 (12.2) | 37 (11.6) |
Ethnic origin (%) | ||
Caucasian | 273 (99 %) | 277 (98 %) |
Other | 4 (1 %) | 5 (2 %) |
Mean years with HDM AA (SD) | 13.3 (10.6) | 12.9 (11.5) |
Control level at randomisation (%)a | ||
Controlled | 0 (0 %) | 0 (0 %) |
Partly controlled | 200 (72 %) | 200 (71 %) |
Uncontrolled | 77 (28 %) | 82 (29 %) |